In particular, we found that two specific molecular markers were able to further stratify the patients at intermediate risk according to ISUP LS: IF-detected OCT4+ tumour cell density was used to stratify patients into intermediate–high and intermediate–low groups (Figure 8A). The gene discussed is POU5F1; the disease is neoplasm.